rs138189536

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 4P and 9B. PM1PM5BP4_StrongBP6BS1

The NM_005957.5(MTHFR):​c.136C>T​(p.Arg46Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000101 in 1,614,076 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R46Q) has been classified as Likely pathogenic.

Frequency

Genomes: 𝑓 0.00011 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00010 ( 0 hom. )

Consequence

MTHFR
NM_005957.5 missense

Scores

7
12

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1U:1B:1

Conservation

PhyloP100: 2.41

Publications

16 publications found
Variant links:
Genes affected
MTHFR (HGNC:7436): (methylenetetrahydrofolate reductase) The protein encoded by this gene catalyzes the conversion of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate, a co-substrate for homocysteine remethylation to methionine. Genetic variation in this gene influences susceptibility to occlusive vascular disease, neural tube defects, colon cancer and acute leukemia, and mutations in this gene are associated with methylenetetrahydrofolate reductase deficiency.[provided by RefSeq, Oct 2009]
MTHFR Gene-Disease associations (from GenCC):
  • homocystinuria due to methylene tetrahydrofolate reductase deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, ClinGen, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 6 uncertain in NM_005957.5
PM5
Other missense variant is known to change same aminoacid residue: Variant chr1-11802980-C-T is described in ClinVar as Likely_pathogenic. ClinVar VariationId is 187867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP4
Computational evidence support a benign effect (MetaRNN=0.018184662).
BP6
Variant 1-11802981-G-A is Benign according to our data. Variant chr1-11802981-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 187866.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.000105 (16/152262) while in subpopulation EAS AF = 0.00309 (16/5182). AF 95% confidence interval is 0.00194. There are 0 homozygotes in GnomAd4. There are 9 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MTHFRNM_005957.5 linkc.136C>T p.Arg46Trp missense_variant Exon 2 of 12 ENST00000376590.9 NP_005948.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MTHFRENST00000376590.9 linkc.136C>T p.Arg46Trp missense_variant Exon 2 of 12 1 NM_005957.5 ENSP00000365775.3

Frequencies

GnomAD3 genomes
AF:
0.000105
AC:
16
AN:
152144
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00308
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000199
AC:
50
AN:
251318
AF XY:
0.000265
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000289
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00217
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000352
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000101
AC:
147
AN:
1461814
Hom.:
0
Cov.:
31
AF XY:
0.000113
AC XY:
82
AN XY:
727198
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33480
American (AMR)
AF:
0.0000224
AC:
1
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26134
East Asian (EAS)
AF:
0.00227
AC:
90
AN:
39700
South Asian (SAS)
AF:
0.000209
AC:
18
AN:
86232
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53420
Middle Eastern (MID)
AF:
0.000347
AC:
2
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000261
AC:
29
AN:
1111966
Other (OTH)
AF:
0.000116
AC:
7
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
10
19
29
38
48
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000105
AC:
16
AN:
152262
Hom.:
0
Cov.:
32
AF XY:
0.000121
AC XY:
9
AN XY:
74442
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41536
American (AMR)
AF:
0.00
AC:
0
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00309
AC:
16
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68030
Other (OTH)
AF:
0.00
AC:
0
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000127
Hom.:
0
Bravo
AF:
0.000246
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00
AC:
0
ExAC
AF:
0.000222
AC:
27
Asia WGS
AF:
0.00115
AC:
4
AN:
3478
EpiCase
AF:
0.00
EpiControl
AF:
0.000119

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Homocystinuria due to methylene tetrahydrofolate reductase deficiency Pathogenic:1Benign:1
Nov 11, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
University Children's Hospital, University of Zurich
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not specified Uncertain:1
Apr 16, 2025
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: MTHFR c.136C>T (p.Arg46Trp) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.0002 in 251318 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in MTHFR causing Homocystinuria Due To Methylene Tetrahydrofolate Reductase Deficiency, allowing no conclusion about variant significance. c.136C>T has been observed in the homozygous and compound heterozygous state in multiple individuals affected with clinical features of Methylene Tetrahydrofolate Reductase Deficiency (Froese_2016, Burda_2015, Chang_2021, Monies_2019). An exome-wide association study (ExWAS) for tHCY in 5,175 individuals of Chinese Han origin showed that this variant resulted in elevated homocystiene (Liu_2021). These data indicate that the variant is very likely to be associated with disease. This variant is also known as c.148C>T. At least one publication reports experimental evidence evaluating an impact on protein function. The most pronounced variant effect results in 30%-50% of normal activity in vitro in a yeast model system (example, Weile_2021). A different variant affecting the same codon has been classified as likely pathogenic at Labcorp (c.137G>A, p.Arg46Gln), supporting the critical relevance of codon 46 to MTHFR protein function. The following publications have been ascertained in the context of this evaluation (PMID: 25736335, 33000330, 35578252, 26872964, 34707639, 31130284, 34214447, 33571559, 32038468, 32722525, 30687093, 16272757, 35359558, 29391032, 35008593, 30887117, 29722429, 36813871, 34214447, 35322348, 27743313, 26025547, 31562900, 31068897, 34426522, 32289814, 28645778, 34737766, 34845156). ClinVar contains an entry for this variant (Variation ID: 187866). Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.24
T
BayesDel_noAF
Benign
-0.13
CADD
Benign
21
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.46
T;.;.;T;.;.;.;.
Eigen
Uncertain
0.21
Eigen_PC
Benign
0.18
FATHMM_MKL
Benign
0.59
D
LIST_S2
Uncertain
0.91
.;D;.;D;D;D;D;D
M_CAP
Benign
0.083
D
MetaRNN
Benign
0.018
T;T;T;T;T;T;T;T
MetaSVM
Uncertain
-0.11
T
MutationAssessor
Uncertain
2.5
M;.;.;M;.;.;.;.
PhyloP100
2.4
PrimateAI
Benign
0.41
T
PROVEAN
Benign
-1.2
N;N;N;N;.;.;.;D
REVEL
Uncertain
0.52
Sift
Benign
0.14
T;T;T;T;.;.;.;D
Sift4G
Benign
0.085
T;T;T;T;.;.;.;.
Polyphen
0.99
D;.;.;D;.;.;.;.
Vest4
0.31
MVP
0.98
MPC
0.27
ClinPred
0.11
T
GERP RS
1.4
PromoterAI
-0.029
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.20
gMVP
0.84
Mutation Taster
=12/88
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs138189536; hg19: chr1-11863038; COSMIC: COSV109428124; COSMIC: COSV109428124; API